In a study conducted by Laklai et al. [85], using in vivo models they observed that PDAC showing impaired TGF-β activation signaling, increased β-catenin and YAP/TAZ nuclear localization and activity, developed a stiffer, fibrotic matrix associated with a more aggressive tumor and a poorer overall survival. The gene discussed is TGFB1; the disease is neoplasm.